ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,848, issued on Jan. 20, was assigned to The Children's Hospital of Philadelphia (Philadelphia).
"Protein C zymogen and methods of use thereof to prevent cancer metastases" was invented by Valder R. Arruda (Philadelphia), Katherine A. High (Merion Station, Pa.), Geerte Van Sluis (Amsterdam) and Christoffel Arnoldus Spek (Driebergen, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods useful for the inhibition of cancer metastasis are disclosed."
The patent was filed on Aug. 27, 2012, under Application No. 13/595,460.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/n...